PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT)

Historical Holders from Q3 2024 to Q4 2025

Type / Class
Equity / Ordinary shares, no par value per share
Symbol
PPBT on Nasdaq
Shares outstanding
2,006,543,493
Price per share
$0.66
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
132,492
Total reported value
$75,782
% of total 13F portfolios
0%
Share change
+70,524
Value change
+$9,481
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
11
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTRACOASTAL CAPITAL, LLC 10% 0% $115,100,512 +$34,923,545 200,453,695 +44% Mitchell P. Kopin 30 Sep 2025
Lincoln Alternative Strategies LLC 9.9% $1,288,650 605,000 Lincoln Alternative Strategies LLC 04 Sep 2025
Orca Capital AG 4.9% $652,619 306,394 Orca Capital AG 04 Sep 2025
As of 30 Sep 2025, PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) has 11 institutional shareholders filing 13F forms. They hold 132,492 shares. of 2,006,543,493 outstanding shares (0.01%) .

Institutional Holders of PURPLE BIOTECH LTD. - Ordinary shares, no par value per share (PPBT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 2,836 $1,865 -$6,456 $0.66 1
2025 Q3 132,492 $75,782 +$9,481 $0.57 11
2025 Q2 56,968 $133,604 +$12,851 $2.34 10
2025 Q1 50,573 $134,236 -$128,880 $2.66 7
2024 Q4 80,346 $376,821 -$567,896 $4.69 12
2024 Q3 170,369 $945,992 +$925,596 $5.56 9